OK for a mouse but not for man

Posted on by

Alzheimer; News from the web:

One of the more vexing problems bedeviling Alzheimer’s research is why so many treatments that are successful in mouse models fail in clinical trials with humans. In a paper published yesterday in Nature Medicine, a team of researchers at the Gladstone Institutes identified how a key genetic variant associated with the development of Alzheimer’s operates differently in mice and humans. They also showed that the problematic gene can be repaired.

Read all about it HERE

Lyft for Alzheimer’s

Posted on by

Alzheimer; News from the web:

The transportation service Lyft is teaming up with the Global Alzheimer’s Platform Foundation to help those who are participating in an Alzheimer’s trial get to and from U.S. and Canadian research sites.

Read all about it HERE

Low dopamine may indicate early Alzheimer’s

Posted on by

Alzheimer; News from the web:

A new study reports a newly discovered link between the loss of dopamine-firing cells in the brain and the brain’s ability to form new memories. It questions the implications of these findings regarding Alzheimer’s disease.

Read all about it HERE

New biomarkers for Alzheimer’s found

Posted on by

Alzheimer; News from the web:

Research from the University of Texas at San Antonio suggests that the plaques that cause the symptoms of Alzheimer’s disease may be more complicated than previously believed, a finding that could significantly affect drug development for the disease.

Researchers found that in addition to the sticky proteins called amyloid beta, other neural and repair proteins also exist within the plaques, indicating new biomarkers for the disease that affects more than 5 million people in the United States.

Read all about it HERE